Jacques Feldmar
Directeur/Bestuurslid bij OBS Medical Ltd.
Profiel
Dr. Jacques Feldmar is a Director-International Marketing at Intrasense SA.
He received his doctorate degree from the Institut National de Recherche en Informatique et en Automati and a doctorate degree from Ecole Polytechnique.
Actieve functies van Jacques Feldmar
| Bedrijven | Functie | Begin |
|---|---|---|
OBS Medical Ltd.
 OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Directeur/Bestuurslid | 05-06-2018 |
Eerdere bekende functies van Jacques Feldmar
| Bedrijven | Functie | Einde |
|---|---|---|
| INTRASENSE | Verkoop & Marketing | - |
Opleiding van Jacques Feldmar
| Institut National de Recherche en Informatique et Automatique | Doctorate Degree |
| Ecole Polytechnique | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTRASENSE | Technology Services |
| Bedrijven in privébezit | 1 |
|---|---|
OBS Medical Ltd.
OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Electronic Technology |
